老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

FSD Pharma Inc

5.84
0.0000
成交量：- -
成交额：213.06万
市值：3.83亿
市盈率：-23.59
高：5.84
开：5.84
低：5.84
收：5.84
52周最高：109.19
52周最低：4.68
股本：6,551.37万
流通股本：4,115.86万
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):-0.2477
每股收益(LYR):-0.4522
净资产收益率：-64.03%
总资产收益率：-33.74%
市净率：31.82
市盈率(LYR):-12.92

数据加载中...

总览公司新闻资讯公告
2024/04/02

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/29

SEC问询函

Form CORRESP - Correspondence
2023/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/01

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/17

年度报告

40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2021/02/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/07/31

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/03/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/17

[修订]年度报告

[Amend] Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2020/03/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/04

年度报告

Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2020/02/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]